GILD vs LITE · P/E 18, rev $29.44B vs P/E 153, rev $3.01B
Gilead Sciences Inc (GILD) versus Lumentum Holdings Inc (LITE) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Lumentum Holdings Inc (LITE) is a communication equipment company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported LITE revenue for 2026-06-27 was $3.01B. Net income was -$6.94B. Revenue was up 83.2% from 2025-06-28 to 2026-06-27. LITE currently screens at market cap $67.72B and trailing P/E 153.0.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. LITE currently screens at market cap $67.72B and trailing P/E 153.0.
Not investment advice. Open the GILD and LITE stock pages for the full models.
Not investment advice.